220 related articles for article (PubMed ID: 8937711)
21. Lipopolysaccharide of Helicobacter pylori protects gastric mucosa via generation of nitric oxide.
Brzozowski T; Konturek PC; Sliwowski Z; Drozdowicz D; Pajdo R; Stachura J; Hahn EG; Konturek SJ
J Physiol Pharmacol; 1997 Dec; 48(4):699-717. PubMed ID: 9444618
[TBL] [Abstract][Full Text] [Related]
22. Comparison of effects of nitric oxide synthase (NOS) inhibitors on plasma nitrite/nitrate levels and tissue NOS activity in septic organs.
Hayashi Y; Abe M; Murai A; Shimizu N; Okamoto I; Katsuragi T; Tanaka K
Microbiol Immunol; 2005; 49(2):139-47. PubMed ID: 15722599
[TBL] [Abstract][Full Text] [Related]
23. Effects of aminoguanidine on nitric oxide production induced by inflammatory cytokines and endotoxin in cultured rat hepatocytes.
Zhang GL; Wang YH; Teng HL; Lin ZB
World J Gastroenterol; 2001 Jun; 7(3):331-4. PubMed ID: 11819785
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury.
Chatterjee PK; Patel NS; Kvale EO; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Thiemermann C
Kidney Int; 2002 Mar; 61(3):862-71. PubMed ID: 11849439
[TBL] [Abstract][Full Text] [Related]
25. Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors.
Mitchell JA; Kohlhaas KL; Sorrentino R; Warner TD; Murad F; Vane JR
Br J Pharmacol; 1993 May; 109(1):265-70. PubMed ID: 7684306
[TBL] [Abstract][Full Text] [Related]
26. L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase.
Moore WM; Webber RK; Jerome GM; Tjoeng FS; Misko TP; Currie MG
J Med Chem; 1994 Nov; 37(23):3886-8. PubMed ID: 7525961
[TBL] [Abstract][Full Text] [Related]
27. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition.
Millar CG; Thiemermann C
Br J Pharmacol; 1997 Aug; 121(8):1824-30. PubMed ID: 9283724
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase.
Hey C; Boucher JL; Vadon-Le Goff S; Ketterer G; Wessler I; Racké K
Br J Pharmacol; 1997 Jun; 121(3):395-400. PubMed ID: 9179379
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
[TBL] [Abstract][Full Text] [Related]
30. Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies.
Hajri A; Metzger E; Vallat F; Coffy S; Flatter E; Evrard S; Marescaux J; Aprahamian M
Br J Cancer; 1998 Oct; 78(7):841-9. PubMed ID: 9764573
[TBL] [Abstract][Full Text] [Related]
31. Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms.
Brandi ML; Hukkanen M; Umeda T; Moradi-Bidhendi N; Bianchi S; Gross SS; Polak JM; MacIntyre I
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2954-8. PubMed ID: 7535933
[TBL] [Abstract][Full Text] [Related]
32. Determination of brain nitric oxide synthase inhibition in vivo: ex vivo assays of nitric oxide synthase can give incorrect results.
Salter M; Duffy C; Hazelwood R
Neuropharmacology; 1995 Mar; 34(3):327-34. PubMed ID: 7543191
[TBL] [Abstract][Full Text] [Related]
33. Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease.
McCartney-Francis NL; Song X; Mizel DE; Wahl SM
J Immunol; 2001 Feb; 166(4):2734-40. PubMed ID: 11160339
[TBL] [Abstract][Full Text] [Related]
34. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
Handy RL; Moore PK
Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895
[TBL] [Abstract][Full Text] [Related]
35. Functional effects of econazole on inducible nitric oxide synthase: production of a calmodulin-dependent enzyme.
Bogle RG; Vallance P
Br J Pharmacol; 1996 Mar; 117(6):1053-8. PubMed ID: 8882596
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of nitric oxide synthase with pyrazole-1-carboxamidine and related compounds.
Southan GJ; Gauld D; Lubeskie A; Zingarelli B; Cuzzocrea S; Salzman AL; Szabó C; Wolff DJ
Biochem Pharmacol; 1997 Aug; 54(3):409-17. PubMed ID: 9278100
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
Joly GA; Narayanan K; Griffith OW; Kilbourn RG
Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462
[TBL] [Abstract][Full Text] [Related]
38. In vivo pharmacological evaluation of two novel type II (inducible) nitric oxide synthase inhibitors.
Tracey WR; Nakane M; Basha F; Carter G
Can J Physiol Pharmacol; 1995 May; 73(5):665-9. PubMed ID: 7585335
[TBL] [Abstract][Full Text] [Related]
39. GW274150 inhibits nitric oxide production by primary cultures of rat proximal tubular cells.
Chatterjee PK; Kvale EO; Patel NS; Thiemermann C
Med Sci Monit; 2003 Oct; 9(10):BR357-62. PubMed ID: 14523323
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation.
Salvemini D; Wang ZQ; Wyatt PS; Bourdon DM; Marino MH; Manning PT; Currie MG
Br J Pharmacol; 1996 Jun; 118(4):829-38. PubMed ID: 8799551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
